Cala Health

About Cala Health

Cala Health develops wearable neuromodulation therapy for tremor relief. Its Cala kIQ System delivers transcutaneous afferent patterned stimulation (TAPS) to reduce action hand tremors in people with essential tremor and Parkinson’s disease. The system is physician prescribed and FDA-cleared, with patient access through the MyCala portal and provider networks in the United States. The company emphasizes on-demand therapy, clinical evidence, and Medicare/VA coverage support for tremor management.